Goldman Sachs’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $52.2K | Buy |
|
|||||
|
2024
Q4 | $44K | Buy |
|
|||||
|
2024
Q3 | $13.9K | Sell |
|
|||||
|
2024
Q2 | $483K | Sell |
|
|||||
|
2024
Q1 | $824K | Buy |
|
|||||
|
2023
Q4 | $610K | Sell |
|
|||||
|
2023
Q3 | $1.67M | Buy |
|
|||||
|
2023
Q2 | $3.15M | Buy |
|
|||||
|
2023
Q1 | $1.82M | Sell |
|
|||||
|
2022
Q4 | $1.87M | Buy |
|
|||||
|
2022
Q3 | $1.71M | Sell |
|
|||||
|
2022
Q2 | $1.62M | Sell |
|
|||||
|
2022
Q1 | $4.47M | Sell |
|
|||||
|
2021
Q4 | $10.3M | Buy |
|
|||||
|
2021
Q3 | $3.98M | Sell |
|
|||||
|
2021
Q2 | $17.2M | Sell |
|
|||||
|
2021
Q1 | $18.7M | Buy |
|
|||||
|
2020
Q4 | $18.2M | Buy |
|
|||||
|
2020
Q3 | $2.62M | Sell |
|
|||||
|
2020
Q2 | $1.74M | Buy |
|
|||||
|
2020
Q1 | $594K | Buy |
|
|||||
|
2019
Q4 | $565K | Buy |
|
|||||
|
2019
Q3 | $459K | Sell |
|
|||||
|
2019
Q2 | $2.02M | Buy |
|
|||||
|
2019
Q1 | $743K | Buy |
|
|||||
|
2018
Q4 | $313K | Sell |
|
|||||
|
2018
Q3 | $613K | Buy |
|
|||||
|
2018
Q2 | $621K | Buy |
|
|||||
|
2018
Q1 | $297K | Sell |
|
|||||
|
2017
Q4 | $502K | Buy |
|
|||||
|
2017
Q3 | $460K | Buy |
|
|||||
|
2017
Q2 | $263K | Sell |
|
|||||
|
2017
Q1 | $501K | Buy |
|
|||||
|
2016
Q4 | $352K | Buy |
|
|||||
|
2016
Q3 | $244K | Buy |
|
|||||
|
2016
Q2 | $424K | Sell |
|
|||||
|
2016
Q1 | $1.53M | Buy |
|
|||||
|
2015
Q4 | $741K | Buy |
|
|||||
|
2015
Q3 | $357K | Buy |
|